• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Re: Efficacy and safety of valrubicin for the treatment of Bacillus Calmette-Guerin refractory carcinoma in situ of the bladder.

作者信息

Klotz L

出版信息

J Urol. 2000 Nov;164(5):1666.

PMID:11025741
Abstract
摘要

相似文献

1
Re: Efficacy and safety of valrubicin for the treatment of Bacillus Calmette-Guerin refractory carcinoma in situ of the bladder.关于：法柔比星治疗卡介苗难治性膀胱原位癌的疗效与安全性
J Urol. 2000 Nov;164(5):1666.
2
Efficacy and safety of valrubicin for the treatment of Bacillus Calmette-Guerin refractory carcinoma in situ of the bladder. The Valrubicin Study Group.缬柔比星治疗卡介苗难治性膀胱原位癌的疗效与安全性。缬柔比星研究组。
J Urol. 2000 Mar;163(3):761-7.
3
Intravesical valrubicin in patients with bladder carcinoma in situ and contraindication to or failure after bacillus Calmette-Guérin.膀胱原位癌且卡介苗治疗禁忌或失败的患者的膀胱内 VALrubicin。
Urol Oncol. 2013 Nov;31(8):1635-42. doi: 10.1016/j.urolonc.2012.04.010. Epub 2012 May 9.
4
The limits of bacillus Calmette-Guerin for carcinoma in situ of the bladder.卡介苗对膀胱原位癌的治疗局限
J Urol. 2001 Mar;165(3):745-56.
5
Valrubicin: an alternative to radical cystectomy for carcinoma in situ of the bladder.
Urol Nurs. 2001 Feb;21(1):30-1, 34-6.
6
Factors affecting valrubicin response in patients with bacillus Calmette-Guérin-refractory bladder carcinoma in situ.影响卡介苗难治性原位膀胱癌患者对盐酸表柔比星反应的因素。
Postgrad Med. 2011 May;123(3):28-34. doi: 10.3810/pgm.2011.05.2281.
7
Radical cystectomy after bacillus Calmette-Guérin for high-risk Ta, T1, and carcinoma in situ: defining the risk of initial bladder preservation.卡介苗治疗高危Ta、T1和原位癌后行根治性膀胱切除术：明确初始膀胱保留的风险
Urology. 2006 Apr;67(4):737-41. doi: 10.1016/j.urology.2005.10.012.
8
Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.荷兰合作试验最新情况：丝裂霉素与卡介苗-蒂策株菌对比卡介苗-荷兰国家公共卫生与环境研究所菌株治疗pTA-pT1期乳头状癌及膀胱原位癌患者。荷兰东南部合作泌尿外科组
Semin Urol Oncol. 1996 Feb;14(1 Suppl 1):10-6.
9
Management of patients with Bacilli Calmette-Guérin-refractory carcinoma in situ of the urinary bladder: cost implications of a clinical trial for valrubicin.
Clin Ther. 2000 Apr;22(4):422-38. doi: 10.1016/s0149-2918(00)89011-6.
10
The case for conservative management in the treatment of patients with non-muscle-invasive micropapillary bladder carcinoma without carcinoma in situ.非肌层浸润性微乳头型膀胱癌且无原位癌患者保守治疗的病例分析
Can J Urol. 2010 Oct;17(5):5370-6.